Sp1 binding sites inserted into the Rous sarcoma virus long terminal repeat enhance LTR-driven gene expression

Gene

Volumn 208, Issue 1, 1998, Pages 73-82

  MacHoň, Ondřej ^a   Strmen, Veronika ^a   Hejnar, Jiří ^a   Geryk, Josef ^a   Svoboda, Jan ^a  

^a INSTITUTE OF MOLECULAR GENETICS   (Czech Republic)

Author keywords

CpG island; DNA protein interaction; Gene silencing; Proviral DNA methylation; Retroviral integration

Indexed keywords

TRANSCRIPTION FACTOR SP1; VIRUS DNA;

ANIMAL CELL; ARTICLE; BINDING SITE; DNA INTEGRATION; DNA METHYLATION; ENHANCER REGION; GENE CONSTRUCT; GENE EXPRESSION; GENE INSERTION; GENETIC TRANSFECTION; LONG TERMINAL REPEAT; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; REPORTER GENE; ROUS SARCOMA ONCOVIRUS;

ANIMALS; AVIAN SARCOMA VIRUSES; BINDING SITES; CELL LINE; DNA METHYLATION; GENE EXPRESSION REGULATION, VIRAL; GENES, REPORTER; PLASMIDS; REPETITIVE SEQUENCES, NUCLEIC ACID; SP1 TRANSCRIPTION FACTOR; TRANSFECTION; TUMOR CELLS, CULTURED;

ANIMALIA; MAMMALIA; ONCOVIRINAE; RICE STRIPE VIRUS; RNA VIRUSES; ROUS SARCOMA VIRUS;

EID: 0032536487     PISSN: 03781119     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-1119(97)00659-8     Document Type: Article

References (52)

1. Akroyd J., Fincham V.J., Green A.R., Levantis P., Searle S., Wyke J.A. Transcription of Rous sarcoma proviruses in rat cells is determined by chromosomal position effects that fluctuate and can operate over long distances. Oncogene. 1:1987;347-354.
2. Barnhart M.K., Connor L.M., Marriott S.J. Function of the human T-cell leukemia virus type 1 21-base-pair repeats in basal transcription. J. Virol. 71:1997;337-344.
3. Berg J.M. Sp1 and the subfamily of zinc finger proteins with guanine-rich binding sites. Proc. Natl. Acad. Sci. USA. 89:1992;11109-11110.
4. Bird A.P. CpG-rich islands and the function of DNA methylation. Nature. 321:1986;209-213.
5. Bird A.P. CpG islands as gene markers in the vertebrate nucleus. Trends Genet. 3:1987;342-347.
6. Bird A.P. Functions for DNA methylation in vertebrates. Cold Spring Harbor Symp. Quant. Biol. 58:1993;281-285.
7. Bodor J., Poliak E., Pichrtová J., Geryk J., Svoboda J. Complete nucleotide sequence of LTR, v-src, LTR provirus H-19. Nucl. Acids Res. 17:1989;8869.
8. Bodor J., Svoboda J. The LTR, v-src, LTR provirus generated in the mammalian genome by v-src mRNA reverse transcription and integration. J. Virol. 63:1989;1015-1018.
9. Brandeis M., Fran D., Keshet I., Siegfried Z., Mendelsohn M., Nemes A., Temper V., Razin A., Cedar H. Sp1 elements protect a CpG island from de novo methylation. Nature. 371:1994;435-438.
10. Bucher P. Weight matrix descriptions of four eukaryotic RNA polymerase II promoter elements derived from 502 unrelated promoter sequences. J. Mol. Biol. 212:1990;563-578.
11. Chen J.-L., Attardi L.D., Verrijzer C.P., Yokomori K., Tjian R. Assembly of recombinant TFIID reveals differential coactivator requirements for distinct transcriptional activators. Cell. 79:1994;93-105.
12. Cullen B.R., Raymond K., Ju G. Functional analysis of the transcription control region located within the avian retroviral long terminal repeat. Mol. Cell. Biol. 5:1985;438-447.
13. Diamond L. Two spontaneously transformed cell lines derived from the same hamster embryo culture. Int. J. Cancer. 2:1967;143-152.
14. Dignam J.D., Lebowitz R.M., Roeder R.G. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian cells. Nucl. Acids Res. 11:1983;1475-1489.
15. Fincham V.J., Wyke J.A. Differences between cellular integration sites of transcribed and nontranscribed Rous sarcoma proviruses. J. Virol. 65:1991;461-463.
16. Fincham V.J., Wyke J.A. On the structure, genesis and significance of the DNA duplications at the Rous sarcoma proviral insertion sites in rat-1 cells. J. Gen. Virol. 73:1992;3247-3250.
17. Green A.R., Searle S., Gillespie D.A.F., Bissell M., Wyke J.A. Expression of integrated Rous sarcoma viruses DNA rearrangements 5′ to the provirus are common in transformed rat cells but not seen in infected but untransformed cells. EMBO J. 5:1986;707-711.
18. Griffin G.E., Leung K., Folks T.M., Kunkel S., Nabel G.J. Activation of HIV gene expression during monocyte differentiation by induction of NF-kB. Nature. 339:1989;70-73.
19. Guntaka R.V., Gowda S., Wagner H., Simon D. Methylation of the enhancer region of avian sarcoma virus long terminal repeat suppresses transcription. FEBS Lett. 221:1987;332-336.
20. Guntaka R.V., Kandala J.C., Shin B.A., Nambiar A., Svoboda J., Cleavinger P. Host- and tissue-specific factors that interact with the enhancer sequences of Rous sarcoma virus LTR. Folia Biol. (Praha). 40:1994;237-247.
21. Harrich D., Garcia J., Foon W., Mitsuyasu R., Gonzales J., Gaynor R. Role of Sp1-binding domains in in vivo transcriptional regulation of the human immunodeficiency virus type 1 long terminal repeat. J. Virol. 63:1989;2585-2591.
22. Hejnar J., Svoboda J., Geryk J., Fincham V.J., Hák R. High rate of morphological reversion in tumor cell line H-19 associated with permanent transcriptional suppression of LTR, v-src LTR provirus. Cell Growth Differ. 5:1994;277-285.
23. Ilyinskii P.O., Desrosiers R.C. Efficient transcription and replication of simian immunodeficiency virus in the absence of NF-κB and Sp1 binding elements. J. Virol. 70:1996;3118-3126.
24. Jones K.A., Kadonaga J.T., Luciw P.A., Tjian R. Activation of the AIDS retrovirus promoter by the cellular transcription factor Sp1. Science. 232:1986;755-759.
25. Kadonaga J.T., Jones K.A., Tjian R. Promoter-specific activation of RNA polymerase II transcription by Sp1. Trends Biochem. Sci. 11:1986;20-23.
26. Kafri T., Ariel M., Brandeis M., Shemer R., Urven L., McCarrey J., Cedar H., Razin A. Developmental pattern of gene-specific DNA methylation in the mouse embryo. Genes Dev. 6:1992;704-714.
27. Koken S.E., van Wamel J.L., Goudsmit J., Berkhout B., Geelen J.L. Natural variants of the HIV-1 long terminal repeat: analysis of promoters with duplicated DNA regulatory motifs. Virology. 191:1992;968-972.
28. Laybourn P.J., Kadonaga J.T. Role of nucleosomal cores and histone H1 in regulation of transcription by RNA polymerase II. Science. 254:1991;238-245.
29. Machoň O., Hejnar J., Hájková P., Geryk J., Svoboda J. The LTR, v-src, LTR provirus in H-19 hamster tumor cell line is integrated adjacent to the negative regulatory region. Gene. 174:1996;9-17.
30. Macleod D., Charlton J., Mullins J., Bird A.P. Sp1 sites in the mouse aprt gene promoter are required to prevent methylation of the CpG island. Genes Dev. 8:1994;2282-2292.
31. Marin M., Karis A., Visser P., Grosveld F., Philipsen S. Transcription factor Sp1 is essential for early embryonic development but dispensable for cell growth and differentiation. Cell. 89:1997;619-628.
32. Mastrangelo I.A., Courey A.J., Wall J.S., Jackson S.P., Hough P.V.C. DNA looping and Sp1 multimers links: a mechanism for transcriptional synergism and enhancement. Proc. Natl. Acad. Sci. USA. 88:1991;5670-5674.
33. Moscovici C. Leukemic transformation with avian myeloblastosis virus: present status. Curr. Top. Microbiol. Immunol. 71:1975;79-101.
34. Nelson D.T., Goodchild N.L., Mager D.L. Gain of Sp1 sites and loss of repressor sequences associated with a young, transcriptionally active subset of HERV-H endogenous long terminal repeats. Virology. 220:1996;213-218.
35. Norton P.A., Coffin J.M. Characterization of Rous sarcoma virus sequences essential for viral gene expression. J. Virol. 61:1987;1171-1179.
36. Overbeek P.A., Lai S.-P., Van Quill K.R., Westphal H. Tissue-specific expression in transgenic mice of a fused gene containing RSV terminal sequences. Science. 231:1986;1574-1577.
37. Perkins N.D., Edwards N.L., Colin S.D., Agranoff A.B., Schmid R.M., Nabel G.J. A cooperative interaction between NF-κB and Sp1 is required for HIV-1 enhancer activation. EMBO J. 12:1993;3551-3558.
38. Pondel M.D., Murphy S., Pearson L., Craddock C., Proudfoot N.J. Sp1 functions in a chromatin-dependent manner to augment human α-globin promoter activity. Proc. Natl. Acad. Sci. USA. 92:1995;7237-7241.
39. Prince V.E., Rigby P.W.J. Derivatives of Moloney murine sarcoma virus capable of being transcribed in embryonal carcinoma stem cells have gained a functional Sp1 binding site. J. Virol. 65:1991;1803-1811.
40. Ruddell A. Transcription regulatory elements of the avian retroviral long terminal repeat. Virology. 206:1995;1-7.
41. Sambrook, J., Fritsch, E.F., Maniatis, T., 1989. Molecular Cloning. A Laboratory Manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
42. Seed B., Sheen Y. A simple-phase extraction assay for CAT activity. Gene. 67:1988;271-277.
43. Sherman M.I., Miller R.A. F9 embryonal carcinoma cells can differentiate into endoderm-like cells. Dev. Biol. 63:1978;27-34.
44. Silke J., Rother K.I., Georgiev O., Schaffner W., Matsuo K. Complex demethylation patterns at Sp1 binding sites in F9 embryonal carcinoma cells. FEBS Lett. 370:1995;170-174.
45. Sjottem E., Anderssen S., Johansen T. The promoter activity of long terminal repeats of the HERV-H family of human retrovirus-like elements is critically dependent on Sp1 family proteins interacting with a GC/GT box located immediately 3′ to the TATA box. J. Virol. 70:1996;188-198.
46. Stewart C.L., Stuhlmann H., Jahner D., Jaenisch R. De novo methylation, expression, and infectivity of retroviral genomes into embryonal carcinoma cells. Proc. Natl. Acad. Sci. USA. 79:1982;4098-4102.
47. Stuhlmann H., Jahner D., Jaenisch R. Infectivity and methylation of retroviral genomes is correlated with expression in the animal. Cell. 26:1981;221-232.
48. Sune C., Garcia-Blanco M.A. Sp1 transcription factor is required for in vitro basal and Tat-activated transcription from the human immunodeficiency virus type 1 long terminal repeat. J. Virol. 69:1995;6572-6576.
49. Varmus H.E., Guntaka R.V., Deng C.-T., Bishop J.M. Synthesis, structure and function of avian sarcoma virus-specific DNA in permissive and non-permissive cells. Cold Spring Harbor Symp. Quant. Biol. 39:1975;987-996.
50. Venkatesh L.K., Arens M.Q., Subramanian T., Chinnadurai G. Selective induction of toxicity to human cells expressing human immunodeficiency virus type 1 Tat by a conditionally cytotoxic adenovirus vector. Proc. Natl. Acad. Sci. USA. 87:1990;8746-8750.
51. Wyke J.A., Quade K. Infection of rat cells by avian sarcoma virus: factors affecting transformation and subsequent reversion. Virology. 106:1980;217-233.
52. Yeivin A., Levine A., Razin A. DNA methylation patterns in tumors derived from F9 cells resemble methylation at the blastula cells. FEBS Lett. 395:1996;11-16.